Vertex Pharmaceuticals
VRTX
#175
Rank
โ‚ฌ100.30 B
Marketcap
391,21ย โ‚ฌ
Share price
-0.41%
Change (1 day)
-9.96%
Change (1 year)

Vertex Pharmaceuticals (VRTX) - Cash on Hand

Cash on Hand as of September 2025 : โ‚ฌ5.39 Billion

According to Vertex Pharmaceuticals's latest financial reports the company has โ‚ฌ5.39 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Vertex Pharmaceuticals - Cash on Hand chart (from 1996 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31โ‚ฌ5.87 B-42.09%
2023-12-31โ‚ฌ10.14 B0.99%
2022-12-31โ‚ฌ10.04 B51.23%
2021-12-31โ‚ฌ6.64 B22.73%
2020-12-31โ‚ฌ5.41 B59.25%
2019-12-31โ‚ฌ3.39 B22.75%
2018-12-31โ‚ฌ2.76 B59.09%
2017-12-31โ‚ฌ1.74 B27.64%
2016-12-31โ‚ฌ1.36 B43.05%
2015-12-31โ‚ฌ0.95 B-16.41%
2014-12-31โ‚ฌ1.14 B7.51%
2013-12-31โ‚ฌ1.06 B6.21%
2012-12-31โ‚ฌ0.99 B33.87%
2011-12-31โ‚ฌ0.74 B-3.78%
2010-12-31โ‚ฌ0.77 B-13.54%
2009-12-31โ‚ฌ0.89 B50.68%
2008-12-31โ‚ฌ0.59 B88.57%
2007-12-31โ‚ฌ0.31 B-40.89%
2006-12-31โ‚ฌ0.53 B75.16%
2005-12-31โ‚ฌ0.30 B7.07%
2004-12-31โ‚ฌ0.28 B-38.53%
2003-12-31โ‚ฌ0.46 B-23.75%
2002-12-31โ‚ฌ0.60 B-27.82%
2001-12-31โ‚ฌ0.84 B72.37%
2000-12-31โ‚ฌ0.48 B161.59%
1999-12-31โ‚ฌ0.18 B815.17%
1998-12-31โ‚ฌ20.39 M-66.15%
1997-12-31โ‚ฌ60.25 M104.87%
1996-12-31โ‚ฌ29.41 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Gilead Sciences
GILD
โ‚ฌ6.31 B 16.89%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
โ‚ฌ4.87 B-9.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ15.64 B 189.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ14.17 B 162.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚ฌ15.94 B 195.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Enanta Pharmaceuticals
ENTA
โ‚ฌ0.17 B-96.75%๐Ÿ‡บ๐Ÿ‡ธ USA